Remove 2023 Remove Health IT Remove healthcare technology Remove Leadership
article thumbnail

HIMSS Europe 2023: Health that Connects + Tech that Cares

Lloyd Price

The event brings together healthcare professionals, thought leaders, and solution providers from across the region to share insights, learn about the latest trends, and collaborate on solutions to improve patient care. HIMSS Europe 2023 will be held in Lisbon, Portugal from June 7-9, 2023.

article thumbnail

Business of Healthcare and Value Based Care – 2023 Health IT Predictions

Healthcare IT Today

As we head into 2023, we wanted to kick off the new year with a series of 2023 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Jon Kimerle, Epic Alliance Manager at Pure Storage.

Health IT 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Average multiples in HealthTech M&A during 2023

Lloyd Price

Exec Summary Overall, 2023 presented a mixed picture for HealthTech M&A. The average multiples in HealthTech M&A declined in 2023 compared to 2022. in 2023 (a decrease of 20%) EV/EBITDA: Down from 12.5x in 2023 (a decrease of 12%) Averages by sub-sector: Telehealth: 5.5x Healthcare IT: 3.5x in 2022 to 4.5x

article thumbnail

Average multiples in HealthTech M&A : November 2023

Lloyd Price

Exec Summary The average multiples in HealthTech M&A deals in 2023 have declined compared to 2022, reflecting a more cautious approach by investors in the face of broader economic challenges. As of November 2023, the average enterprise value (EV) to sales multiple is 4.5x, down from 5.6x Healthcare IT companies: 3.5x

article thumbnail

Orforglipron: the new kid on the GLP-1 block

Lloyd Price

Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.

article thumbnail

Average Multiples and Key Drivers of Digital Musculoskeletal (MSK) M&A deals in 2023

Lloyd Price

Executive Summary: Digital MSK (musculoskeletal) companies have seen a decline in valuation multiples in 2023 compared to 2022. However, as of November 2023, the average EV to sales multiple has declined to 5.5x. However, as of November 2023, the average EV to EBITDA multiple has declined to 10.0x. Email lloyd@nelsonadvisors.co.uk